Mark Douglas Gorrell

Title: Mark Douglas Gorrell: Innovator in Peptidase and Antigen Research

Introduction

Mark Douglas Gorrell is a notable inventor based in Sydney, New South Wales, Australia. He has made significant contributions to the field of biochemistry, particularly in the development of peptides and protective antigens against disease pathogens. With a total of two patents to his name, Gorrell's work has implications for vaccine development and diagnostic tools.

Latest Patents

Gorrell's latest patents include innovative peptides that demonstrate peptidase ability and substrate specificity for various compounds. These peptides include sequences such as HisGlyTrpSerTyrGlyGlyPheLeu and LeuAspGluAsnValHisPhePhe. Additionally, he has developed methods and kits for identifying protective antigens from pathogens. These antigens are crucial for providing protection to animals against specific diseases. The methods involve isolating protective antigens using antibody probes derived from immune animals, which can be utilized in vaccine preparation and diagnostic applications.

Career Highlights

Throughout his career, Gorrell has focused on advancing the understanding of peptidases and their applications in medicine. His research has contributed to the development of new therapeutic strategies and diagnostic tools that can enhance disease prevention and treatment.

Collaborations

Gorrell has collaborated with notable colleagues, including Elza Nicole Theresia Meeusen and Malcolm Roy Brandon. These partnerships have fostered a collaborative environment that promotes innovation and the sharing of ideas in the field of biochemistry.

Conclusion

Mark Douglas Gorrell is a distinguished inventor whose work in peptide and antigen research has the potential to impact medical science significantly. His contributions continue to pave the way for advancements in vaccine development and disease diagnostics.